The following is a summary of “Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: Insights from the CREDENCE trial,” published in the February 2025 issue of Nephrology Dialysis ...

High-protein diets boost weight loss, but too much can backfire. Why excess protein might be slowing your fat loss and how to ...

Researchers from the German Diabetes Center (DDZ) and the Heinrich Heine University Düsseldorf (HHU) have studied the ...

A Brazilian study published in the journal Nutrients suggests that fish oil can weaken insulin resistance and reduce glucose ...

Kura Oncology's (KURA) ziftomenib shows AML promise amid competition. See why I'm inclined to view the current price levels ...

Watch the Caffeine. Some teas, like green and black tea, naturally contain caffeine. So, if you’re sensitive to caffeine, you ...

ZyVersa Therapeutics (ZVSA) highlights newly published data demonstrating cardioprotective effects and improvements in metabolic parameters ...

The liver is a vital organ responsible for detoxifying toxins. Certain foods can 'clean out your liver' and reduce your risk of fatty liver disease.

A Brazilian study published in Nutrients suggests that fish oil may help reduce insulin resistance and improve glucose ...

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

Researchers suggest a better understanding of the neural basis for thermoregulation during motion sickness may provide ...

Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure.